G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL.
Ilaria IacobucciReiji FukanoJake D FriskeChunxu QuLaura J JankeYaqi ZhaoPradyuamna BaviskarEmily A BackhausPeter J ChockleyAman SethA Douglas LairdAnjali S AdvaniCharles G MullighanPublished in: Blood advances (2022)